BCM
Burrage Capital Management Portfolio holdings
AUM
$99.7M
1-Year Return
65.92%
This Quarter Return
+121.71%
1 Year Return
+65.92%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$149M
AUM Growth
–
Cap. Flow
+$149M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
69.97%
Holding
29
New
29
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
EPZM
Epizyme, Inc
EPZM
|
+$23.8M |
| 2 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$14.2M |
| 3 |
ARQL
Arqule Inc
ARQL
|
+$11.9M |
| 4 |
GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
|
+$11M |
| 5 |
PTC Therapeutics
PTCT
|
+$9.4M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 95.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Solid Biosciences
SLDB
$420M
| $358K | 0.24% |
+5,366
| New | +$358K |
|
|
VIRX
27
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $185K | 0.12% |
+15,664
| New | +$185K |
|
|
AUTL
28
Autolus Therapeutics
AUTL
$367M
| $173K | 0.12% |
+13,113
| New | +$173K |
|
|
KDNY
29
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $160K | 0.11% |
+27,180
| New | +$160K |
|